Cargando…
Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)
Co-morbid depression is common in patients with diabetes mellitus and has a negative impact on diabetes self-care, adherence to treatment and the development of complications. Effective treatment of depression has been associated with improvement in metabolic parameters. We evaluated the feasibility...
Autores principales: | Abrahamian, Heidemarie, Hofmann, Peter, Prager, Rudolf, Toplak, Hermann |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695229/ https://www.ncbi.nlm.nih.gov/pubmed/19557120 |
Ejemplares similares
-
Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group)
por: Abrahamian, Heidemarie, et al.
Publicado: (2012) -
Austrian Experience with Lixisenatide Under Real-Life Conditions: A Prospective Observational Study
por: Brath, Helmut, et al.
Publicado: (2019) -
Psychische und neurokognitive Erkrankungen und Diabetes mellitus (Update 2023)
por: Abrahamian, Heidemarie, et al.
Publicado: (2023) -
Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
por: Hofmann, Peter
Publicado: (2010) -
Milnacipran: recent findings in depression
por: Montgomery, Stuart, et al.
Publicado: (2010)